Erectile dysfunction as a sentinel marker of endothelial dysfunction disease

Introduction: Vascular disease is the major underlying cause of erectile dysfunction (ED). Endothelial dysfunction acts as a marker of "peripheral vascular disease" that occurs prior to clinical vascular disease. ED is the first clinical manifestation of endothelial disease due to the smal...

Full description

Saved in:
Bibliographic Details
Main Authors: Bannakij Lojanapiwat, T. Weerusawin, S. Kuanprasert
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=68249122296&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59818
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-59818
record_format dspace
spelling th-cmuir.6653943832-598182018-09-10T03:21:57Z Erectile dysfunction as a sentinel marker of endothelial dysfunction disease Bannakij Lojanapiwat T. Weerusawin S. Kuanprasert Medicine Introduction: Vascular disease is the major underlying cause of erectile dysfunction (ED). Endothelial dysfunction acts as a marker of "peripheral vascular disease" that occurs prior to clinical vascular disease. ED is the first clinical manifestation of endothelial disease due to the small size of the penile artery. Brachial f low-mediated vasodilation (FMD) is one of the accurate tests for evaluating endothelial function. We compared the endothelial function by FMD between ED patients without clinical signs of vascular disease and non-ED patients. Methods: 41 ED patients and 30 age-matched normal control subjects were assessed for cardiovascular risks and endothelial function. We measured the FMD in order to evaluate the endothelial function, by comparing the percentage change of the brachial arterial diameter after the brachial arterial occlusion. Results: There were no significant differences in baseline characteristics, cardiovascular risks and lipid values between both groups, except that the high-density lipoprotein cholesterol was higher in the control group. The percentage change of the FMD was 8.7 +/- 1.0 percent and 5.1 +/- 0.6 percent in ED patients and control subjects, respectively (p-value is 0.007). Conclusion: ED is the first clinical presentation of sub- cl inical endothel ial dys funct ion disease prior to the appearance of clinical cardiovascular disease or cardiovascular risk factors. ED can be the sentinel marker of early cardiovascular and other systemic vascular diseases and it should thus be employed in preventive strategies. 2018-09-10T03:21:57Z 2018-09-10T03:21:57Z 2009-07-01 Journal 00375675 2-s2.0-68249122296 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=68249122296&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/59818
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
spellingShingle Medicine
Bannakij Lojanapiwat
T. Weerusawin
S. Kuanprasert
Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
description Introduction: Vascular disease is the major underlying cause of erectile dysfunction (ED). Endothelial dysfunction acts as a marker of "peripheral vascular disease" that occurs prior to clinical vascular disease. ED is the first clinical manifestation of endothelial disease due to the small size of the penile artery. Brachial f low-mediated vasodilation (FMD) is one of the accurate tests for evaluating endothelial function. We compared the endothelial function by FMD between ED patients without clinical signs of vascular disease and non-ED patients. Methods: 41 ED patients and 30 age-matched normal control subjects were assessed for cardiovascular risks and endothelial function. We measured the FMD in order to evaluate the endothelial function, by comparing the percentage change of the brachial arterial diameter after the brachial arterial occlusion. Results: There were no significant differences in baseline characteristics, cardiovascular risks and lipid values between both groups, except that the high-density lipoprotein cholesterol was higher in the control group. The percentage change of the FMD was 8.7 +/- 1.0 percent and 5.1 +/- 0.6 percent in ED patients and control subjects, respectively (p-value is 0.007). Conclusion: ED is the first clinical presentation of sub- cl inical endothel ial dys funct ion disease prior to the appearance of clinical cardiovascular disease or cardiovascular risk factors. ED can be the sentinel marker of early cardiovascular and other systemic vascular diseases and it should thus be employed in preventive strategies.
format Journal
author Bannakij Lojanapiwat
T. Weerusawin
S. Kuanprasert
author_facet Bannakij Lojanapiwat
T. Weerusawin
S. Kuanprasert
author_sort Bannakij Lojanapiwat
title Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
title_short Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
title_full Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
title_fullStr Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
title_full_unstemmed Erectile dysfunction as a sentinel marker of endothelial dysfunction disease
title_sort erectile dysfunction as a sentinel marker of endothelial dysfunction disease
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=68249122296&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/59818
_version_ 1681425321695379456